For decades, politicians have claimed marijuana is a gateway to heroin and harder drugs. Federal youth surveys, NSDUH data, and NIDA’s own language tell a different story. Cannabis use is widespread, hard drug use remains rare, and most users do not progress. The data dismantles one of prohibition’s most durable fear narratives.
Medical Marijuana and the Paycheck
Workplace Wars continues in New Jersey, where Senate Bill S3452 would protect registered medical cannabis patients from metabolite-only drug test punishment. The proposal shifts the burden to employers, requiring proof by a preponderance of the evidence that lawful medical use caused on-duty impairment, backed by specific articulable symptoms. It also keeps the written notice and three-day explanation or retest process.
OHIO’S LEGALIZATION FIGHT IS ABOUT CONTROL, NOT CANNABIS
Ohio voters approved adult use cannabis with 57 percent support in 2023. Two years later, lawmakers narrowed that framework through Senate Bill 56. A referendum campaign now seeks to overturn those revisions, requiring roughly 248,000 valid signatures statewide. This piece breaks down what changed, who changed it, and what voters are being asked to decide next.
THE CANNABIS LIE: Vol. 1
This new investigative series begins by confronting one of cannabis policy’s most durable myths. THC percentage became a convenient shortcut for harsher laws, even though higher potency has never equaled greater danger. Vol. 1 documents how numbers replaced evidence and how courts, media, and policy still punish people for a claim that cannot survive scrutiny.
How Cannabis Can Cost You Your Gun
Federal law still allows cannabis use to strip Americans of firearm rights without proof of danger or misuse. As the Supreme Court weighs United States v. Hemani, courts are confronting whether the government can continue punishing people based on status rather than conduct in a country where cannabis is legal in most states.
David Krumholtz and the Collapse of Nuance
Actor David Krumholtz’s experience with Cannabinoid Hyperemesis Syndrome sparked a backlash that reveals a deeper problem in cannabis culture. This piece examines how rare conditions get weaponized, why defensive reactions backfire, and how patients, veterans, and families are erased when nuance collapses on both sides of the cannabis debate.